Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors Peer median
Gross Margin for ODTX and competitors
Company Period LTM level YoY 3-year change
ANABAnaptysBio, Inc.LTM Mar 2026116.4% +166.6 pp+862.2 pp
PTGXProtagonist Therapeutics, Inc.LTM Jun 202699.9% -0.1 pp-2.7 pp
ALMSAlumis Inc. Common StockLTM Jun 202688.2% -7.7 pp—
ACRSAclaris Therapeutics, Inc.LTM Mar 202676.3% +55.8 pp+13.5 pp
SYRESpyre Therapeutics, Inc.LTM Sep 202650.0% ——
ODTXOdyssey Therapeutics, Inc.—— ——
ORKAOruka Therapeutics, Inc.FY2025— ——
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024— ——
IMUXImmunic, Inc.FY2025— ——
Peer median (excluding ODTX) 88.2%+27.8 pp+13.5 pp

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.